Related Experiment Video
Updated: May 7, 2026
04:41
Ex Vivo Calcium Imaging for Drosophila Model of Epilepsy
Published on: October 13, 2023
Epilepsy and vitamin D.
András Holló1, Zsófia Clemens, Péter Lakatos
11National Institute for Medical Rehabilitation , Budapest , Hungary.
The International Journal of Neuroscience
|September 26, 2013
Summary
Vitamin D deficiency is increasingly linked to neurological disorders like epilepsy. This review explores the evidence, suggesting vitamin D plays a role in epilepsy
Area of Science:
- Neurology
- Endocrinology
- Nutritional Science
Background:
- Vitamin D deficiency is associated with various systemic and neurological disorders.
- Neurological conditions like multiple sclerosis, Alzheimer's, and Parkinson's disease have known links to vitamin D.
- Epilepsy, a prevalent neurological disorder, has received less attention regarding its connection to vitamin D.
Purpose of the Study:
- To review existing evidence linking vitamin D to epilepsy.
- To examine the interaction between antiepileptic drugs and vitamin D levels.
- To assess the role of vitamin D in the pathophysiology of epilepsy.
Main Methods:
- Review of ecological studies.
- Review of interventional studies.
- Review of animal studies.
- Literature assessment on drug-nutrient interactions.
Main Results:
- Converging evidence suggests a connection between vitamin D deficiency and epilepsy.
- Studies indicate a potential role for vitamin D in the development and progression of epilepsy.
- Interactions between antiepileptic drugs and vitamin D metabolism are noted.
Conclusions:
- Vitamin D deficiency may contribute to the pathophysiology of epilepsy.
- Further research is warranted to elucidate the precise mechanisms.
- Understanding this link could inform novel therapeutic strategies for epilepsy.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...